Aarey Drugs EBITDA vs. Net Income
| AAREYDRUGS | 59.74 1.57 2.70% |
EBITDA | First Reported 2010-12-31 | Previous Quarter 114.2 M | Current Value 58.3 M | Quarterly Volatility 41.2 M |
For Aarey Drugs profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Aarey Drugs to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Aarey Drugs Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Aarey Drugs's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Aarey Drugs Pharmaceuticals over time as well as its relative position and ranking within its peers.
Aarey |
Aarey Drugs Pharmace Net Income vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Aarey Drugs's current stock value. Our valuation model uses many indicators to compare Aarey Drugs value to that of its competitors to determine the firm's financial worth. Aarey Drugs Pharmaceuticals is number one stock in ebitda category among its peers. It also is number one stock in net income category among its peers making up about 0.41 of Net Income per EBITDA. The ratio of EBITDA to Net Income for Aarey Drugs Pharmaceuticals is roughly 2.44 . At this time, Aarey Drugs' EBITDA is relatively stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aarey Drugs' earnings, one of the primary drivers of an investment's value.Aarey Net Income vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Aarey Drugs |
| = | 114.16 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Aarey Drugs |
| = | 46.84 M |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Aarey Net Income Comparison
Aarey Drugs is currently under evaluation in net income category among its peers.
Aarey Drugs Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Aarey Drugs, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Aarey Drugs will eventually generate negative long term returns. The profitability progress is the general direction of Aarey Drugs' change in net profit over the period of time. It can combine multiple indicators of Aarey Drugs, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 24.6 M | 18 M | |
| Operating Income | 2.8 M | 2.7 M | |
| Income Before Tax | 53.4 M | 46.5 M | |
| Net Income | 46.8 M | 47.9 M | |
| Income Tax Expense | 6.6 M | 12 M | |
| Total Other Income Expense Net | 50.6 M | 53.1 M | |
| Net Interest Income | -43.8 M | -41.6 M | |
| Interest Income | 23.7 M | 19.2 M | |
| Net Income From Continuing Ops | 46.8 M | 45.8 M | |
| Net Income Applicable To Common Shares | 75.3 M | 69.5 M | |
| Change To Netincome | 21.8 M | 21.8 M |
Aarey Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Aarey Drugs. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Aarey Drugs position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Aarey Drugs' important profitability drivers and their relationship over time.
Use Aarey Drugs in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aarey Drugs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aarey Drugs will appreciate offsetting losses from the drop in the long position's value.Aarey Drugs Pair Trading
Aarey Drugs Pharmaceuticals Pair Trading Analysis
The ability to find closely correlated positions to Aarey Drugs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aarey Drugs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aarey Drugs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aarey Drugs Pharmaceuticals to buy it.
The correlation of Aarey Drugs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aarey Drugs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aarey Drugs Pharmace moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aarey Drugs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Aarey Drugs position
In addition to having Aarey Drugs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Debt ETFs Thematic Idea Now
Broad Debt ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Debt ETFs theme has 230 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Debt ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Aarey Stock Analysis
When running Aarey Drugs' price analysis, check to measure Aarey Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarey Drugs is operating at the current time. Most of Aarey Drugs' value examination focuses on studying past and present price action to predict the probability of Aarey Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarey Drugs' price. Additionally, you may evaluate how the addition of Aarey Drugs to your portfolios can decrease your overall portfolio volatility.